Balchem's balance sheet is fortress-like, with debt-to-equity at 0.13 and total debt down to $166.7M from $321.5M in 2024Q1, while current ratio stands at 2.66.
Balchem Corp (BCPC) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 388.42M | 365.61M | 313.77M | 314.24M | 335.8M | 322.23M | 266.89M | 254.95M | 226.31M | 199.34M | 188.44M | 198.83M | 181.3M | 277.77M | 211.91M | 175.74M | 129.65M | 93.01M | 55.25M | 52.47M | 28.86M | 35.27M | 29.21M | 23.63M | 18.81M | 17.02M | 11.37M | 9.1M | 8.4M | 7.3M | 5.6M |
| Cash & Short-Term Investments | 63.17M | 74.57M | 49.52M | 64.45M | 66.56M | 103.24M | 84.57M | 65.67M | 54.27M | 40.42M | 38.64M | 84.8M | 50.29M | 208.75M | 144.74M | 114.78M | 77.25M | 46.43M | 3.42M | 2.31M | 5.19M | 13M | 12.73M | 9.24M | 1.73M | 3.12M | 3.07M | 1.7M | 1.3M | 700K | 100K |
| Cash Only | 63.17M | 74.57M | 49.52M | 64.45M | 66.56M | 103.24M | 84.57M | 65.67M | 54.27M | 40.42M | 38.64M | 84.8M | 50.29M | 208.75M | 144.74M | 114.78M | 77.25M | 46.43M | 3.42M | 2.31M | 5.19M | 13M | 12.73M | 9.24M | 1.73M | 3.12M | 3.07M | 1.7M | 1.3M | 700K | 100K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 148.97M | 143.6M | 119.66M | 125.28M | 131.58M | 117.41M | 98.21M | 93.44M | 99.55M | 91.23M | 83.25M | 60.48M | 71.98M | 39.39M | 42M | 34.43M | 32.05M | 29.15M | 30.25M | 29.64M | 11.58M | 11.52M | 8M | 7.23M | 7.16M | 7.13M | 5.04M | 4M | 3.3M | 3.1M | 3M |
| Days Sales Outstanding | 48.6 | 50.53 | 45.8 | 49.57 | 50.96 | 53.63 | 50.95 | 52.99 | 56.45 | 55.98 | 54.93 | 39.96 | 48.53 | 42.64 | 49.39 | 43.06 | 45.86 | 48.48 | 47.58 | 61.4 | 41.88 | 5.01 | 43.3 | 42.67 | 43.41 | 56.4 | 55.46 | 49.16 | 41.97 | 39.56 | 41.48 |
| Inventory | 161.55M | 131.45M | 130.8M | 109.52M | 119.67M | 91.06M | 70.62M | 83.89M | 67.19M | 60.7M | 57.24M | 46.09M | 49.62M | 24.82M | 20.69M | 18.64M | 15.72M | 13.96M | 16.62M | 15.68M | 9.92M | 8.54M | 6.32M | 5.96M | 7.24M | 5.58M | 2.55M | 2.7M | 2.9M | 2.5M | 1.9M |
| Days Inventory Outstanding | 75.48 | 71.98 | 77.32 | 64.44 | 65.99 | 59.79 | 53.73 | 70.83 | 55.81 | 54.6 | 56.12 | 43.76 | 45.6 | 37.79 | 34.2 | 33.04 | 32.41 | 33.43 | 33.8 | 44.27 | 54.11 | 57.28 | 52.9 | 53.43 | 71.62 | 72.12 | 54.38 | 63.17 | 67.85 | 59.64 | 50.62 |
| Other Current Assets | 5.33M | 6.22M | 5.74M | 7.19M | 13.09M | 4.41M | 3.44M | 7.55M | 1.48M | 2.22M | 5.19M | 3.72M | 4.87M | 2.24M | 1.11M | 954K | 1.1M | 1.42M | 2.38M | 2.39M | 416K | 276K | 321K | 474K | 403K | 214K | 200K | 700K | 900K | 1M | 600K |
| Total Non-Current Assets | 1.3B | 1.34B | 1.26B | 1.28B | 1.29B | 877.09M | 898.96M | 900.74M | 755.04M | 764.3M | 760.18M | 682.39M | 679.97M | 99.1M | 100.64M | 95.98M | 98.97M | 94.8M | 99.22M | 101.95M | 63.48M | 39.88M | 31.19M | 33.28M | 34.49M | 27.45M | 11.85M | 12.9M | 14.2M | 10.3M | 9.5M |
| Property, Plant & Equipment | 318.82M | 322.84M | 299.2M | 295.9M | 290.79M | 246.81M | 236.51M | 224.2M | 194.34M | 189.79M | 165.75M | 158.51M | 131.59M | 54.92M | 52.73M | 44.28M | 43.39M | 41.58M | 42.51M | 42.08M | 31.31M | 24.4M | 24.19M | 25.64M | 25.85M | 17.9M | 7.76M | 7.8M | 8.1M | 7.3M | 7.5M |
| Fixed Asset Turnover | 3.41x | 3.21x | 3.19x | 3.12x | 3.24x | 3.24x | 2.98x | 2.87x | 3.31x | 3.13x | 3.34x | 3.49x | 4.11x | 6.14x | 5.89x | 6.59x | 5.88x | 5.28x | 5.46x | 4.19x | 3.22x | 34.39x | 2.79x | 2.41x | 2.33x | 2.58x | 4.28x | 3.81x | 3.54x | 3.92x | 3.52x |
| Goodwill | 808.81M | 816.38M | 780.03M | 778.91M | 769.51M | 523.95M | 529.46M | 524M | 448M | 441.36M | 439.81M | 383.91M | 383.65M | 28.52M | 28.52M | 28.52M | 28.52M | 26.66M | 26.66M | 26.36M | 25.25M | 13.33M | 6.37M | 6.37M | 6.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 151.64M | 163.29M | 165.05M | 191.21M | 213.29M | 94.67M | 121.66M | 143.92M | 105.98M | 128.07M | 147.48M | 134.91M | 160.39M | 15.13M | 18.86M | 22.71M | 26.65M | 26.5M | 29.99M | 33.45M | 6.91M | 2.15M | 637K | 1.27M | 2.24M | 9.55M | 4.09M | 5.1M | 6.1M | 2.9M | 2M |
| Long-Term Investments | 14.55M | 3.72M | 3.86M | 4.08M | 4.29M | -46.45M | -51.36M | -56.43M | 4.9M | 4.8M | 4.55M | -810K | -1.39M | -893K | -47.97M | -556K | -552K | -891K | 0 | -515K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 15.74M | 14.42M | 13.46M | 12.87M | -51.96M | 11.67M | 11.33M | 8.62M | -42.49M | -48.28M | 1.87M | 5.06M | 4.34M | 541K | 47.91M | 474K | 420K | 60K | 59K | 61K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 0 |
| Total Assets | 1.69B | 1.71B | 1.58B | 1.6B | 1.62B | 1.2B | 1.17B | 1.16B | 981.36M | 963.64M | 948.63M | 881.22M | 861.27M | 376.87M | 312.55M | 271.72M | 228.62M | 187.81M | 154.47M | 154.42M | 92.33M | 75.14M | 60.41M | 56.91M | 53.3M | 44.48M | 23.22M | 22M | 22.6M | 17.6M | 15.1M |
| Asset Turnover | 0.64x | 0.61x | 0.61x | 0.58x | 0.58x | 0.67x | 0.60x | 0.56x | 0.66x | 0.62x | 0.58x | 0.63x | 0.63x | 0.89x | 0.99x | 1.07x | 1.12x | 1.17x | 1.50x | 1.14x | 1.09x | 11.17x | 1.12x | 1.09x | 1.13x | 1.04x | 1.43x | 1.35x | 1.27x | 1.63x | 1.75x |
| Asset Growth % | 17.64% | 8.39% | -1.37% | -1.68% | 35.45% | 2.87% | 0.88% | 17.76% | 1.84% | 1.58% | 7.65% | 2.32% | 128.53% | 20.58% | 15.03% | 18.85% | 21.73% | 21.58% | 0.03% | 67.25% | 22.88% | 24.4% | 6.15% | 6.77% | 19.83% | 91.53% | 5.55% | -2.65% | 28.41% | 16.56% | 5.59% |
| Total Current Liabilities | 145.75M | 176.38M | 157.69M | 148.49M | 140.04M | 143.8M | 94.43M | 92.26M | 82.06M | 108.4M | 101.01M | 81.12M | 95.52M | 35.75M | 30.23M | 30.91M | 29.51M | 33.81M | 25.68M | 36.33M | 9.56M | 9.15M | 5.71M | 6.08M | 7.93M | 6.48M | 3.28M | 2.8M | 3.5M | 3.6M | 3.5M |
| Accounts Payable | 70.45M | 60.42M | 54.74M | 55.5M | 57.32M | 56.24M | 23.74M | 37.27M | 33.79M | 28.45M | 32.51M | 14.71M | 24.35M | 12.39M | 14.28M | 11.53M | 9.76M | 10.88M | 10.34M | 11.19M | 3.01M | 2.56M | 1.47M | 1.25M | 2.78M | 2.88M | 970K | 600K | 1.1M | 2.7M | 2.5M |
| Days Payables Outstanding | 32.79 | 33.09 | 32.36 | 32.66 | 31.61 | 36.93 | 18.06 | 31.46 | 28.07 | 25.59 | 31.87 | 13.97 | 22.38 | 18.87 | 23.59 | 20.44 | 20.11 | 26.03 | 21.02 | 31.6 | 16.42 | 17.19 | 12.27 | 11.24 | 27.49 | 37.32 | 20.65 | 14.04 | 25.74 | 64.41 | 66.61 |
| Short-Term Debt | 3.38M | 3.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35M | 35M | 35M | 35M | 0 | 0 | 1.39M | 1.48M | 6.78M | 4.9M | 10.59M | 0 | 0 | 0 | 1.74M | 1.74M | 1.75M | 0 | 600K | 1.2M | 800K | 700K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40K | 0 | 0 | 0 | 42K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 51.96M | 77.18M | 22.89M | 17.23M | 16.54M | 19.57M | 48.6M | 41.46M | 2.26M | 13.85M | 12.09M | 13.46M | 11.42M | 7.86M | 4.14M | 4.29M | 13.56M | 0 | 0 | 5.83M | 4.68M | 4.83M | 2.75M | 389K | 382K | 305K | 521K | 1.6M | 1.2M | 100K | 300K |
| Current Ratio | 2.66x | 2.07x | 1.99x | 2.12x | 2.40x | 2.24x | 2.83x | 2.76x | 2.76x | 1.84x | 1.87x | 2.45x | 1.90x | 7.77x | 7.01x | 5.68x | 4.39x | 2.75x | 2.15x | 1.44x | 3.02x | 3.85x | 5.12x | 3.89x | 2.37x | 2.63x | 3.47x | 3.25x | 2.40x | 2.03x | 1.60x |
| Quick Ratio | 1.56x | 1.33x | 1.16x | 1.38x | 1.54x | 1.61x | 2.08x | 1.85x | 1.94x | 1.28x | 1.30x | 1.88x | 1.38x | 7.07x | 6.32x | 5.08x | 3.86x | 2.34x | 1.50x | 1.01x | 1.98x | 2.92x | 4.01x | 2.91x | 1.46x | 1.77x | 2.69x | 2.29x | 1.57x | 1.33x | 1.06x |
| Cash Conversion Cycle | 91.29 | 89.43 | 90.76 | 81.35 | 85.34 | 76.49 | 86.61 | 92.35 | 84.19 | 84.99 | 79.17 | 69.75 | 71.75 | 61.56 | 59.99 | 55.67 | 58.16 | 55.88 | 60.36 | 74.08 | 79.57 | 45.11 | 83.93 | 84.86 | 87.54 | 91.2 | 89.18 | 98.29 | 84.08 | 34.79 | 25.49 |
| Total Non-Current Liabilities | 238.87M | 273.76M | 267.77M | 394.74M | 546.19M | 178.51M | 243.18M | 319.76M | 207.68M | 238.36M | 326.58M | 336.4M | 373.85M | 9.76M | 9.3M | 8.79M | 11.65M | 6.86M | 14.28M | 25.01M | 7.41M | 5.06M | 4.46M | 11.05M | 12.1M | 12.67M | 362K | 1.3M | 3.3M | 1.7M | 2.2M |
| Long-Term Debt | 152M | 175.32M | 190M | 309.57M | 440.57M | 108.57M | 163.57M | 248.57M | 156M | 183.96M | 245.49M | 260.96M | 297.5M | 0 | 3.43M | 23K | 3.43M | 0 | 6.67M | 17.4M | 0 | 0 | 0 | 7.84M | 9.58M | 11.32M | 0 | 700K | 2.6M | 800K | 1.4M |
| Capital Lease Obligations | 50.12M | 12.87M | 14.72M | 16.54M | 16.02M | 7.11M | 6.08M | 4.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 229.37M | 75.45M | 43.72M | 52.05M | 62.78M | 46.45M | 51.36M | 56.43M | 44.31M | 48.55M | 74.2M | 67.22M | 70.4M | 5.88M | 5.87M | 5.98M | 5.64M | 5.03M | 6M | 6.09M | 6.63M | 4.01M | 3.46M | 2.23M | 1.56M | 351K | 225K | 400K | 500K | 500K | 500K |
| Other Non-Current Liabilities | 22.59M | 10.12M | 19.34M | 16.58M | 26.81M | 16.37M | 22.18M | 9.93M | 7.37M | 5.85M | 6.9M | 6.68M | 5.95M | 3.88M | 0 | 2.79M | 2.58M | 1.82M | 1.61M | 1.53M | 784K | 1.04M | 1M | 985K | 964K | 994K | 137K | 200K | 200K | 400K | 300K |
| Total Liabilities | 384.63M | 450.15M | 425.46M | 543.23M | 686.23M | 322.31M | 337.61M | 412.01M | 289.74M | 346.75M | 427.59M | 417.52M | 469.37M | 45.51M | 39.53M | 39.71M | 41.16M | 40.67M | 39.97M | 61.34M | 16.97M | 14.21M | 10.17M | 17.13M | 20.03M | 19.14M | 3.64M | 4.1M | 6.8M | 5.3M | 5.7M |
| Total Debt | 166.72M | 192.01M | 208.04M | 330.33M | 460.61M | 118.04M | 171.99M | 255.87M | 156M | 218.96M | 280.49M | 295.96M | 332.5M | 3.88M | 3.43M | 1.41M | 4.91M | 6.78M | 11.57M | 27.99M | 0 | 0 | 0 | 9.58M | 11.32M | 13.07M | 0 | 1.3M | 3.8M | 1.6M | 2.1M |
| Net Debt | 103.54M | 117.44M | 158.53M | 265.89M | 394.05M | 14.8M | 87.41M | 190.2M | 101.73M | 178.55M | 241.85M | 211.17M | 282.21M | -204.87M | -141.31M | -113.37M | -72.34M | -39.65M | 8.15M | 25.68M | -5.19M | -13M | -12.73M | 342K | 9.59M | 9.95M | -3.07M | -400K | 2.5M | 900K | 2M |
| Debt / Equity | 0.13x | 0.15x | 0.18x | 0.31x | 0.49x | 0.13x | 0.21x | 0.34x | 0.23x | 0.35x | 0.54x | 0.64x | 0.85x | 0.01x | 0.01x | 0.01x | 0.03x | 0.05x | 0.10x | 0.30x | - | - | - | 0.24x | 0.34x | 0.52x | - | 0.07x | 0.24x | 0.13x | 0.22x |
| Debt / EBITDA | 0.58x | 0.73x | 0.90x | 1.54x | 2.34x | 0.67x | 1.06x | 1.72x | 1.03x | 1.55x | 2.05x | 2.21x | 2.95x | 0.05x | 0.05x | 0.02x | 0.08x | 0.14x | 0.31x | 0.87x | - | - | - | 0.76x | 0.75x | 1.21x | - | 0.19x | 0.58x | 0.30x | 0.47x |
| Net Debt / EBITDA | 0.36x | 0.45x | 0.69x | 1.24x | 2.00x | 0.08x | 0.54x | 1.28x | 0.67x | 1.26x | 1.76x | 1.58x | 2.50x | -2.69x | -2.04x | -1.73x | -1.24x | -0.81x | 0.22x | 0.80x | -0.23x | -0.66x | -0.79x | 0.03x | 0.64x | 0.92x | -0.39x | -0.06x | 0.38x | 0.17x | 0.44x |
| Interest Coverage | 24.31x | 20.48x | 11.07x | 7.07x | 14.03x | 51.99x | 24.97x | 17.19x | 14.01x | 12.73x | 12.41x | 14.21x | 15.98x | 2743.42x | 5985.40x | 676.45x | 558.01x | 195.27x | 30.52x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.3B | 1.26B | 1.15B | 1.05B | 938.28M | 877.01M | 828.23M | 743.67M | 691.62M | 616.88M | 521.03M | 463.7M | 391.9M | 331.36M | 273.01M | 232.01M | 187.47M | 147.14M | 114.51M | 93.08M | 75.36M | 60.93M | 50.23M | 39.78M | 33.27M | 25.33M | 19.58M | 17.9M | 15.8M | 12.3M | 9.4M |
| Equity Growth % | 28.64% | 9.35% | 9.1% | 12.33% | 6.99% | 5.89% | 11.37% | 7.53% | 12.12% | 18.4% | 12.36% | 18.32% | 18.27% | 21.37% | 17.67% | 23.76% | 27.4% | 28.5% | 23.02% | 23.51% | 23.68% | 21.3% | 26.28% | 19.57% | 31.33% | 29.38% | 9.39% | 13.29% | 28.46% | 30.85% | 27.03% |
| Book Value per Share | 40.39 | 38.57 | 35.15 | 32.48 | 28.97 | 26.84 | 25.48 | 22.88 | 21.32 | 19.14 | 16.32 | 14.66 | 12.57 | 10.74 | 8.99 | 7.67 | 6.33 | 5.10 | 4.01 | 3.35 | 2.74 | 2.26 | 1.92 | 1.57 | 1.33 | 1.03 | 0.81 | 0.72 | 0.62 | 0.50 | 0.40 |
| Total Shareholders' Equity | 1.3B | 1.26B | 1.15B | 1.05B | 938.28M | 877.01M | 828.23M | 743.67M | 691.62M | 616.88M | 521.03M | 463.7M | 391.9M | 331.36M | 273.01M | 232.01M | 187.47M | 147.14M | 114.51M | 93.08M | 75.36M | 60.93M | 50.23M | 39.78M | 33.27M | 25.33M | 19.58M | 17.9M | 15.8M | 12.3M | 9.4M |
| Common Stock | 2.13M | 2.14M | 2.17M | 2.15M | 2.15M | 2.15M | 2.16M | 2.16M | 2.15M | 2.13M | 2.12M | 2.1M | 2.06M | 2.02M | 1.96M | 1.94M | 1.92M | 1.87M | 823K | 804K | 788K | 776K | 508K | 327K | 327K | 327K | 327K | 300K | 0 | 0 | 0 |
| Retained Earnings | 1.21B | 1.12B | 997.49M | 897.49M | 814.49M | 732.14M | 656.74M | 590.92M | 528.03M | 464.64M | 388.09M | 344.2M | 295.2M | 251.63M | 214.61M | 181.07M | 147.54M | 118.58M | 94.88M | 77.84M | 63.99M | 53.31M | 43.4M | 36.06M | 30.81M | 23.77M | 18.97M | 15.5M | 12.7M | 9.9M | 7.3M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | -7.87M | -18.07M | -56K | 0 | 0 | -74K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.16M | 0 | -504K | -1.41M | -2.15M | -2.8M | -900K | 0 | 0 | 0 |
| Accumulated OCI | 27.21M | 41.55M | -23.75M | 8.69M | -7.15M | -4.99M | 4.17M | -5.56M | -3.6M | -1.64M | -6.85M | -5.11M | -2.65M | 198K | -759K | -938K | -549K | 153K | -8K | 150K | 193K | -17.93M | -15.35M | -12.82M | -11.02M | -9.19M | -7.86M | -7M | -6M | -5.2M | -7.2M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying BCPC stock.
As of 2025, Balchem Corp (BCPC) had total assets of $1.71B including $365.6M in current assets.
Balchem Corp (BCPC) carries total debt of $192.0M, offset by $74.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Balchem Corp (BCPC) has total shareholders' equity (book value) of $1.26B ($38.57 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Balchem Corp (BCPC) reported a current ratio of 2.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Ethylene oxide regulatory risk
Metrics are mathematically derived from official filings.
Leverage Declines as Assets Expand
Balchem's total assets grew to $1.7B by 2026Q2, while total debt fell from $321.5M in 2024Q1 to $166.7M, per reported figures, indicating a strengthening balance sheet.
The sequential reduction in debt, from $321.5M to $166.7M over ten quarters, alongside stable asset growth, suggests a deliberate deleveraging trend. This appears to be driven by strong cash generation, as cumulative operating cash flow exceeded net income, per prior analysis. The balance sheet trajectory implies enhanced financial flexibility, which may support future strategic moves without straining liquidity.
Minimal Leverage Provides Strategic Cushion
Debt-to-equity fell to 0.13 in 2026Q2 from 0.30 in 2024Q1, as per financial statements, reflecting a conservative capital structure that insulates Balchem from rising rates.
Total debt of $166.7M against equity of $1.3B yields a D/E ratio of 0.13, which is exceptionally low compared to peers like Ingredion (0.41) and Avient (0.81). This suggests that leverage is not a necessity but a strategic choice, likely to preserve flexibility. The absence of refinancing risk is notable, as the company's cash position of $63.2M covers a significant portion of its debt, though the maturity profile is not disclosed.
Intangible-Heavy Asset Base Signals M&A
Goodwill of $808.8M represents nearly half of total assets, per reported data, indicating a history of acquisitions that may pose impairment risk if growth stalls.
Goodwill and intangibles dominate the asset mix, with goodwill alone at $808.8M versus PPE of $318.8M. This suggests an asset-light operational model reliant on acquired intellectual property, consistent with the company's microencapsulation moat. The steady increase in goodwill from $771.5M in 2024Q1 to $808.8M indicates continued tuck-in acquisitions. Investors should monitor whether organic growth justifies these carrying values, as any sustained underperformance could trigger impairment charges.
Retained Earnings Drive Equity Growth
Retained earnings rose to $1.2B in 2026Q2 from $926.5M in 2024Q1, per reported figures, reflecting strong profit retention and a conservative payout policy.
Equity expanded to $1.3B, primarily fueled by retained earnings, which grew by over $250M in ten quarters. This indicates that management is reinvesting profits into the business rather than distributing them, consistent with the low dividend and moderate buyback activity. The quality of equity is high, as it is built on cumulative earnings rather than financial engineering, though stock-based compensation of ~$4.8M per quarter, per prior analysis, does dilute shareholders modestly.
Liquidity Buffer Remains Robust
Current ratio improved to 2.66 in 2026Q2 from 2.61 in 2024Q1, per reported data, while cash of $63.2M provides a solid cushion against short-term obligations.
With a current ratio above 2.5 consistently, Balchem maintains a strong liquidity position, well above the 1.0 threshold. Cash balances have fluctuated but remain adequate relative to total liabilities of $384.6M. The company's ability to cover short-term obligations without relying on external financing is a key strength, especially given the low debt levels. This liquidity buffer appears sufficient to absorb operational shocks, though the recent EPS miss suggests monitoring cash conversion efficiency.
Goodwill Impairment Risk Lurks
Goodwill of $808.8M, per reported figures, constitutes a significant portion of assets, and any acquisition-related underperformance could lead to impairment charges that erode equity.
The balance sheet's headline strength masks the concentration of intangible assets, which are subject to impairment testing. If the HNH or ANH segments fail to meet growth expectations, the company may need to write down goodwill, directly impacting equity. Additionally, the absence of deferred revenue suggests limited forward visibility from customer prepayments, which may indicate that revenue recognition is tied to point-in-time deliveries rather than long-term contracts. This warrants scrutiny of the durability of the revenue stream.